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ABSTRACT 
Systemic Leptin Modulates the Expression of E-cadherin, β– catenin in the Ovary of Dietary-
Induced Obese Infertile Rats 
by 
Olufunke Abosede Sokan 
One of the numerous complications of obesity is infertility.  Leptin has been shown to reverse 
infertility; however, exact mechanism is poorly understood.  Recent evidence indicates E-
cadherin/β-catenin complex,  which is a structural constituent of adherens junction, is expressed 
in the rat ovary during folliculogenesis.  We hypothesized that systemic leptin modulates the 
expression of E-cadherin and β catenin in dietary- induced obese infertile rats to reverse 
infertility.  Female Sprague-Dawley rats were fed either regular chow diet (RCD) (n=6) or high 
fat diet (HFD) (n=14).  Oestrus cycles were monitored daily until their cycles became irregular.  
100 ug/ml of leptin was given intraperitoneally to HFD-fed rats (n=5) with irregular cycles.  The 
control rats HFD (n=9) and RCD received saline.  Leptin treatment restored regular estrous 
cycle and increased the expression of E-cadherin and β-catenin in all the 5 rats (HFD+Leptin).  
This could represent the mechanism by which leptin reverses infertility in obese infertile rats. 
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CHAPTER 1 
INTRODUCTION 
Leptin 
     Leptin was discovered in 1994 by Zhang and colleagues while they were studying obesity 
among mice (1).  Leptin is a 16kDa protein hormone.  It plays a role in regulating energy intake 
and expenditure which includes appetite, hunger, and metabolism (1).  The major source of 
leptin is from white adipose tissue (2, 3).  It is also secreted from the hypothalamus (4) and 
other peripheral tissues, such as brain (4), stomach (5), skeletal muscle (6), placenta (7), and 
mammary glands (8, 9). 
Function of Leptin in Energy Intake and Expenditure 
     The level of circulating leptin is proportional to the total amount of fat in the body (10).  
Fasting or very low calorie diet has been shown to reduce the level of leptin (3).  Reduced level 
of leptin promotes food intake in excess of energy expenditure in order to restore body fat mass 
(3).  In the absence of functional leptin, animals fail to restrain their food intake, which leads to 
obesity (1).  Leptin usually acts as an afferent hormone regulating appetite, weight gain, and fat 
deposition via a negative feedback loop involving the hypothalamus (1).  Leptin provides the 
body with nutritional index (11).  Leptin enters the hypothalamus in proportion to its plasma level 
and acts on its receptors.  Leptin receptors have been found in the mediobasal part of the 
hypothalamus, which include the arcuate (ARC), dorsomedial hypothalamic, and ventromedial 
hypothalamic nuclei.  These receptors are involved in regulation of energy intake, energy 
expenditure,  thermogenesis, and pituitary hormone levels (12). 
     There are 2 populations of neurons found in the ARC that are sensitive to leptin.  Leptin is 
activated when bound to the first population of neurons, the orexigenic peptides, Neuropeptide 
10 
 
Y (NPY), and Agouti-Related Protein (AgRP) (13).  This activation leads to increase food intake 
and reduction in energy expenditure.  However, the second population of neurons, 
proopiomelanocortin (POMC) and cocaine-and amphetamine-regulated transcript (CART), give 
the opposite effect when bound by leptin (10).  In the peripheral tissues, leptin modulates 
adenosine monophosphate-activated protein kinase (AMPK) (14).  Leptin uses the ATP-
generating pathways (fatty acid oxidation) and avoids ATP-consuming pathways, like fatty acid 
synthesis, in order to restore energy homeostasis of the cell (14). 
      Leptin acts as an anorectic hormone to decrease appetite, food intake, and expenditure via 
various pathways.  This is done in both peripheral and central modes of action in order to 
maintain energy balance (7).  It is worthy of note that leptin has also been found to be a crucial 
hormone for diverse physiological processes such as inflammation, angiogenesis, 
hematopoiesis, immune function, and most importantly in reproduction (15). 
 
Leptin and Reproduction 
     The success of reproduction is much dependent on availability of food and body energy 
stores, with adequate distribution of adipose tissue (16).  Because leptin level is related to 
amount of body fat storage (17), leptin could influence reproductive cycles directly or indirectly.  
Likewise, lack of biologically active leptin is associated with infertility (18).  Leptin is involved in 
centrally regulated maturation of the reproductive structures (19).  This was found in obese 
female ob/ob mice that were infertile (19).  Reversal of their infertility was noted  after 
exogenous leptin treatment (19). Elevation of serum luteinizing hormone, increase in ovarian 
and uterine weights, and stimulation of ovarian and uterine histology were also documented 
(20).  Some studies have also supported the concept that leptin coordinates the behavioral and 
endocrine  components of reproductive function with adequate amount of energy stores (21). 
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Leptin and HPG Axis 
     Leptin accelerates gonadotropin releasing hormone (GnRH) pulsatility (Figure 1), which 
plays a major role in fertility (22).  However, leptin is not the sole regulator of GnRH  secretion 
but works in supporting other molecules through distinct signaling mechanisms and pathways 
(23).  As much as 20% to 25% of the anterior pituitary cells (predominantly folliculostellate and 
corticotropes cells) have been found to produce leptin.  This may act to regulate pituitary 
differentiation and cell growth in addition to its effect on luteinizing hormone and follicular 
stimulating hormone secretion (24).  Previous work demonstrated that low levels of leptin have 
been associated with low levels of luteinizing hormone (LH).  This was reversed when leptin 
was administered (25). 
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Figure 1: Mechanisms of action of leptin in reproductive system.  Leptin acts on the preoptic 
area of the hypothalamus, increasing GnRH secretion.  GnRH stimulates anterior pituitary to 
release FSH.  This causes folliculization in preparedness for ovulation.  LH surge initiates 
ovulation. 
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E-cadherin and Beta-catenin 
 E-Cadherin 
     E-cadherins, also known as CAM 120/80, uvomorulin, or epithelial cadherin, are a subtype in 
the cadherins family (26).  Cadherin family consist of  type-1 transmembrane proteins (27).  In 
this family, there are different subtypes.  Each of the subtypes is designated with a prefix 
depending on the tissue type.   For example, N-cadherin is found in the neurons; K-cadherin in 
the kidney; VE-cadherin in the Vascular endothelium; E-cadherin in the epithelia tissues, etc 
(28).  E-cadherin is the most studied member of the cadherin family (27). 
     E-cadherin is encoded by CH1 gene (26). It was identified in chicken and was originally 
called L-CAM (29).  The mouse counterpart of this protein uvomorulin has about 80% identity in 
both amino acid nucleotide and sequences to the human counterpart (30).  During mammalian 
development, e-cadherin is first expressed at the 2-cell stage of mammalian development.  It 
then becomes phosphorylated by the 8-cell stage where it causes compaction.  E-cadherin’s 
half-life on the cell surface is 5 hours (29).  It is found extracellularly at adherens junctions.  
Adherens junctions are cellular structures near the apical surface of polarized epithelial cells. 
      For E-cadherin to function, it is dependent on calcium (Ca2+) ions (31).  It is composed of 5 
extracellular cadherin repeats, (E1–E5) in the extracellular domain, a transmembrane domain, 
an intracellular domain that binds p120-catenin and beta-catenin, and a highly conserved 
cytoplasmic tail (32). The intracellular domain of E-cadherin has a highly phosphorylated region 
vital to β-catenin binding.  It is known as a tumor suppressor (33) and plays an important role in 
cell adhesion (31).  E-cadherin ensures that the cells within the tissue are well bound together, 
hence playing a vital role in normal tissue development (27).  The binding of p120 to intracellular 
domain of E-cadherin regulates cadherin adhesive activity and trafficking.  Meanwhile the 
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binding of β-catenin and γ-catenin play a structural role in junctional complex.  E-cadherin-
containing cell-to-cell junctions are often adjacent to actin-containing filaments of the 
cytoskeleton in epithelial cells (31).  In addition to the  E-cadherin role in normal cells, it can play 
a major role in malignant cell transformation, tumor development, and progression (31). 
 
β-Catenin 
      β-catenin is a human protein that was found initially to be a member of Armadillo family of 
proteins (Homologous protein in drosophila) (34).  It is encoded by CTNNB1 gene (34), and the 
structure has been determined (35). β-catenin family proteins have been found to contain 
several ARM repeats, sequences of approximately 50 amino acids that are involved in protein-
protein interactions.  Each of these repeat consists of 3 helices with helix 1 and 3 parallel to 
each other and helix 3 perpendicular to helix 1 and 3 (7). 
      β-catenin can be found inside the cell forming complexes with cadherins, axin (a component 
of the Wnt signaling pathway), galectin-3,transcription factors, and beta-galactoside-binding 
protein (36).  It also associates with α-catenin, ICAT (β-catenin interactive protein 1), and APC 
(Adenomatous polyposis coli) (37).  The ability for β-catenin to bind to other proteins is 
regulated by tyrosine kinase and serine kinases like GSK-3 (38, 39).   It serves as an anchor to 
the actin cytoskeleton (38).  This may be responsible for transmitting contact inhibiting signal 
that makes cells stop dividing once the epithelial sheet is complete. 
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Canonical Wnt /β-catenin Signaling Pathway 
     Wnt signaling pathway is a network of several proteins that passes signals from receptors on 
the cell surface through the cytoplasm to the cell’s nucleus (40-42).  Compositions of the 
network are secreted glycoprotein, Wnt family ligand, frizzled and low-density lipoprotein (LDL) 
receptor-related protein (LRP) families of receptors (40-42).  These signals further initiate 
signaling cascade that lead to expression of target genes (41).   Wnt signaling pathway controls 
cell-cell communication during embryo development, adult cell proliferation, and differentiation 
during development and healing (43, 44).  During development, the Wnt signaling pathway 
regulates diverse processes, such as cell fate determination, cell polarity, and morphology, 
structural remodeling and most importantly cell adhesion and growth (40-45).  The frizzled 
receptor component of Wnt signaling pathway is involved in 2 distinct pathways known as 
canonical or non-canonical pathways (45). The presence or absence of β-catenin is the 
difference between these two categories of pathways (45). 
     The canonical Wnt pathway (Wnt/β-catenin signaling pathway) regulates β-catenin 
stabilization and gene expression, thereby causing its accumulation in the cytoplasm (46).  β-
catenin acts as an intracellular signal transducer in the canonical Wnt signaling pathway (47).  
The non-canonical pathway is the signaling pathway that regulates cell polarization (PCP) (48).  
This is a process that establishes the uniform alignment of structures in the epithelium (48).  
       Normal levels of β-catenin are needed to associate with cadherins to promote cell adhesion 
and also control cell shape with the microfilament cytoskeletal network (49).  Without a normal 
level, β-catenin will not be able to carry out its numerous functions (49).  Normal levels of 
cytoplasmic β-catenin are maintained by a regulated process that directs degradation of excess 
β-catenin (49).  In the cytoplasm, β- catenin degradation as shown in figure 2a involves 
phosphorylation by GSK3beta (37, 49, 50).  Cyclin-CDK2 primes β-catenin for phosphorylation 
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by GSK3beta (49, 50).  This phosphorylation occurs within the so-called “destruction-complex” 
scaffold by the tumor suppressors AXINS (49, 50).  Tumor suppressor APC (Adenomatous 
polyposis coli) is also required within this destruction complex for an efficient degradation of β-
catenin (37).  Phosphorylated beta-catenin is then bound by the beta-TrCP component of 
ubiquitin ligase complex and β-catenin is degraded.  GSK3beta, which is constitutively active, 
must be inhibited to prevent the degradation of β-catenin in order for β-catenin to carry out its 
functions (50).  This is where canonical Wnt signaling pathway is involved (51). 
      Canonical Wnt signaling pathway, (figure 2b), through frizzled and LRP receptor (LRP5/6) 
pair, activates dishevelled (Dvl) and inhibits GSK3beta. This allows accumulation of β-catenin in 
the cytoplasm, hence its ability to migrate to the nucleus.  β-catenin enters the nucleus and 
interacts with transcription factors and gene regulators, such as T-cell factor (TCF)/lymphoid 
enhancer factor (LEF) to mediate gene expression (28, 29).  Already bound β-catenins (e.g. E-
cadherin/β-catenin complex) as shown in figure 2c, are not affected by this degradation.  
However, the degradation affects the availability of β-catenin to bind to E-cadherin and other 
proteins (52). 
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Canonical Wnt/β-catenin Signaling Pathway and E-cadherin/β-catenin complex 
 
Figure 2: A. The degradation of beta-catenin by GSK3beta complex.  B. Wnt/β catenin signaling 
pathway enhances accumulation of beta-catenin in the cytoplasm.  C. E-cadherin/β-catenin 
complex. 
 
 
E-cadherin/β- catenin Complex  
      β-catenin is part of a complex that constitutes adherens junctions (27, 31). These adherens 
junctions are needed for the creation and maintenance of epithelial cell layers, through 
regulation cell growth and adhesion between cells (27). 
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      E-cadherin and β-catenin complex play a crucial role in maintaining epithelial integrity (27, 
31). Cell-cell junctions in tissues help to maintain cell and tissue integrity and polarity.  In 
vertebrate animals, there are intercellular junctions systems, namely: Gap junctions (that act as 
intercellular channels and allow direct cell-cell transfer of small molecules and ions); Tight 
junctions (the major cellular determinant of epithelial barrier function); Anchoring junctions 
(these are desmosomes and adheren junctions that interact with the cortical cytoskeleton to 
mediate cell and tissue behavior) (53). Among the structural molecule constituents that 
assemble to form the adheren  junctions is the E-cadherin/β-catenin complex (53). The 
extracellular region of E-cadherin spans from the cell surface of a particular cell to other 
subtypes of cadherins present on adjacent cells.  The intracellular region contains binding sites 
to interact with β-catenins and other regulatory proteins (54).   β-catenin binds to the carboxyl-
terminal 100 amino acids of the cadherin cytoplasmic region.  Actin cytoskeleton, which has the 
ability to promote adherens junction protein clustering and stabilization of cell adhesion, is 
bound to beta-catenin by alpha-catenin (55, 56). 
 
Presence of E-cadherin and β-catenin in Ovary and It’s Relation to Ovulation 
Folliculogenesis 
     In mammals there are different dynamic changes that occur during reproduction cycle. The 
different ovarian compartments are subjected to both differentiation and proliferation events that 
are regulated by paracrine and endocrine factors (57).  Human ovaries normally produce a 
single dominant follicle that results in a single ovulation during each menstrual cycle (57). The 
development and maturation of this dominant ovarian follicle involves structural changes that 
require altered expression and function of the component involved in cell-cell contacts (58).  
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Intercellular communication through the cell-cell adhesion is crucial in the maintenance of tissue 
integrity and function (59).   
     Folliculogenesis is the process of attaining successively higher levels of cell organization by 
means of cytodifferentiation and cell proliferation of the ovarian follicle (60).  This process 
occurs within the cortex of the ovary (56).  The recruitment of a primordial follicle into the pool of 
growing follicles is the beginning of folliculogenesis (57).  This ends with either ovulation or 
death by atresia. Folliculogenesis includes 4 major developmental events as shown in figure 3 
below: 1) primordial follicle recruitment; 2) pre-antral follicle development; 3) selection and 
growth of antral follicle; and 4) follicle atresia (60-62).  The pre-antral phase (gonadotropin-
independent phase) is characterized by growth and differentiation of the oocyte and controlled 
by locally produced growth factors through paracrine/autocrine mechanisms (56-58).  A 
primordial follicle consists of a single layer of flattened or squamous granulosa cells.  These 
granulosa cells are closely juxtaposed to the oocyte and a basal lamina (56).  Primordial follicles 
are formed in the human fetus from the sixth to ninth month of gestation and are arrested in the 
dictyate stage of meiosis (58).  Some of these primordial follicles are recruited to grow soon 
after their formation in the fetus.  This is termed recruitment or primordial follicle activation (56).  
As the female develops and grows into puberty, the primordial follicle becomes primary follicle. 
The primary follicle is characterized by a single layer of one or more cuboidal cells arranged 
around the oocyte (56-58).  It is during the conversion of primordial follicles to primary follicles 
that the importance of cell-cell contacts arises (29). There is a development of intimate 
intercellular connections between the oocyte and granulosa cells (63).  It is believed that the 
effectiveness of adherens junctions and gap junctions in these regions is important in primary 
follicle development (59).  The importance of oocyte-granulosa intercellular connections makes 
the E-cadherin/β-catenin complex a potential candidate for a crucial role in folliculogenesis.  E-
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cadherin/β-catenin is a structural constituent in formation of adherens junction.  This support the 
recent finding of expression of E-cadherin and β-catenin in normal rat ovaries (64, 65). 
     As the pre-antral folliculogenesis continues, the primary follicle develops into secondary 
follicle. Secondary follicle development includes the accumulation of multiple layers of granulosa 
cells around the oocyte and the acquisition of theca cells (theca interna and theca externa) (66).  
This process is regulated by autocrine/paracrine mechanisms that involve growth factors 
produced by the oocyte (56-58).  Primary-to-secondary transition involves the ability to stimulate 
granulosa cell proliferation and continual development of inter-cellular junction system between 
the granulosa cells and oocyte-granulosa intercellular connections (59). 
      The antral phase (gonadotropin-dependent phase) is associated with tremendous size 
increase of the follicle (25-30mm) and regulated by follicular stimulating hormone (FSH), 
luteinizing hormone (LH), and growth factors (57).  Determination of how these growth factor 
pathways negatively or positively regulate folliculogenesis, ovulation, and luteogenesis is not 
completely understood.  The hallmark of the antral phase is the appearance of epitheloid cells in 
the theca interna and development of a fluid filled antrum (61).  The overall size of the antral 
follicle is determined by the size of the antrum (follicular fluid) and proliferation of the follicle 
cells (granulosa and theca cells) (57).  Cessation of increase in follicular fluid and mitosis under 
hormonal influence leads to follicular atresia.  All the granulosa cells express FSH receptors 
during antral follicle development.  This enables them to respond to FSH in many ways, 
including induction of luteinizing hormone (LH) receptors (57).   The stimulation by 
gonodotrophins and growth factors causes the growth of the follicle and granulosa cell 
differentiation, leading to pre-ovulatory follicle.  An LH surge causes follicular rupture (ovulation) 
and formation of corpus luteum (57, 62, 67). Constant communication between the oocyte and 
its surrounding granulosa cells results in maturation of a fertilizable oocyte (59, 63). 
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Figure 3: Folliculogenesis.  The pre-antral and antral follicular growth phase of folliculogenesis.    
(adapted from (69) ) 
Expression of E-cadherin/β-catenin in Rats Ovaries 
      E-cadherin/β-catenin complex plays an important role during tissue development and 
differentiation of many organs (68).  The modulation of E-cadherin-β-catenin expression is an 
integral component of remodeling processes including corpus luteum formation in the ovary 
(64).  Recent studies have suggested the presence of this complex in the theca-interstitial cells 
surrounding pre-ovulatory follicles and pre-antral follicles located in the inner region of the ovary 
(58, 64, 65).  E-cadherin/β-catenin complex has been expressed in the rat ovary during 
folliculogenesis and luteal formation (65).  Expressions of E-cadherin and β-catenin were found 
to be increased in the theca and interstitial cells of the rat ovaries during follicular development. 
However, granulosa cells had more expression of β-catenin (65).  
     The concentration of E-cadherin and β-catenin were found to be constant during the follicular 
phase and present in most ovarian cells at all stages of folliculogenesis (58, 64, 65).  This 
makes them have the potential to participate in the regulation of cytoskeletal structures and 
intracellular signaling.  Studies have shown that modulation of E-cadherin/β-catenin complex 
expression is an integral component of remodeling processes that includes corpus luteum 
formation in the ovary and folliculogenesis (61).  The complex is under hormonal control during 
these processes (20, 34).  The possibility of E-cadherin having a ‘barrier-function’ role in limiting 
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the accessibility of immune system to the follicular compartment during folliculogenesis has also 
been postulated (42). 
     These evidences suggest the involvement of these proteins in reproductive processes. 
However, the molecule modulating the expression of these proteins (E-cadherin and β-catenin) 
in these ovarian cells is unknown at the moment.  Because leptin is a ploteotropic hormone 
involved in many physiological processes including reproduction (15), the fundamental 
questions to be answered are: 1. Is it possible that the direct involvement in modulation of 
expression of these proteins could be one of leptin actions that has not yet been identified?; and 
2. Does leptin work to reverse dietary-induced infertility in an obese rat by modulating E-
cadherin and β-catenin expression in ovarian cells?  This study was designed to answer these 
questions. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
Animals Model 
      Twenty female Sprague-Dawley rats of the same age with the weight range of 220-260g 
were acquired from Harland and used in this study (Protocol #100501).  The animal use 
protocol was approved by the University committee on animal care (UCAC) of East Tennessee 
State University. The animals were housed individually and kept in a well-controlled, specific 
pathogen-free room, located in Brown Hall DLAR facility at ETSU.  Food and water were made 
available ad libitum. Six of the rats were given regular chow diet (RCD), and the remaining 14 
were fed with high Fat diet (HFD).  
Determination of Oestrous Cycle and Vaginal Cytology 
     The oestrus cycles were checked daily for each of the rats. A regular 4-day cycle as shown 
in figure 4, consists of proestrus, estrus, metestrus, and diestrus. 
Vaginal Cytology 
     In determining the different stages of the estrous cycle, a wet mount process was conducted 
to visualize the vaginal cytology.  A small amount (10µl) of saline solution was introduced into 
the vaginal orifice of each female rat and then aspirated and placed on a clean dry slide.  The 
cells were then examined under a compound microscope at 10X and 40X for analysis.  Using a 
digital camera microscope (manufactured by Nikonci, Japan (Figure 6), pictures were taken. 
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Oestrus Cycle 
 
 
 
Figure 4: Vaginal smears pictures that were taken at 10X using digital camera microscope. 
Each of the pictures represents 1 of the 4 cycles of oestrus. (A) Proestrus: predominance of 
nucleated epithelial cells. (B) Estrus: predominance of anucleated cornified cells. (C) Metestrus: 
includes nucleated epithelial cells, anucleated cornified cells, and leukocytes. (D) Diestrus: 
predominance of leukocytes. 
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Irregular Oestrus Cycle 
     The irregularity of the oestrus cycle as shown in figure 5, of those rats given HFD was 
noticed towards the end of the 12th week of the study, which signified the occurrence of 
infertility.  The regularity of oestrus cycle is determined by a 4-day cycle that consists of: 
proestrus, estrus, metestrus, and diestrus.  Ability of each rat to go through this cycle day by 
day without skipping any stage signifies a regular oestrus cycle.  
 
Figure 5: Representation of an irregular oestrus cycle. The cycle moved from (A) Proestrus: 
predominance of nucleated epithelial cells, to (B) Metestrus: includes nucleated epithelial cells, 
anucleatedcornified cells, and leukocytes, skipping Estrus and being detained in (C) Diestrus: 
predominance of leukocytes. 
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Figure 6: Using a digital camera microscope (manufactured by Nikonci, Japan), pictures were 
taken at 10X and 40X magnification for analysis. 
 
 
Overview 
       Diet-induced obesity in rats has been found to lead to infertility in both female and male rats 
(15). Leptin is involved in centrally regulated maturation of the reproductive system.  The 
infertility of obese female ob/ob mice can be reversed by leptin treatment (15).  In order to study 
leptin modulation of expression on E-cadherin, β-catenin in dietary- induced obese infertile rats, 
some of these female rats were given HFD daily.  Their weight, food intake, and oestrus cycle 
were checked daily until the oestrus cycle became irregular. 
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     Six were given RCD and 14 HFD.  By the 13th week, 5 out of the 14 female rats that were fed 
HFD had irregular oestrus cycle earlier than the remaining 9.  These were the rats that were 
treated with leptin. 100ug/ml of leptin was injected to each of the 5 female rats intra-peritoneally 
(morning and evening) for 2 days.  The remaining 9 given HFD and the 6 with RCD were 
injected with saline.  Their body weight and food intake were measured twice weekly and the 
estrus cycle checked daily. 
Statistical Analysis  
      t-test, one-way ANOVA, two-way ANOVA were used to calculate the significant difference of 
the average weight change and food intake amongst the rats. The level of significance was set 
at (p < 0.05). 
 
Tissue Harvesting 
      At the end of the 14th day when the oestrus cycle of those treated with Leptin became 
regular, the 20 female rats were sacrificed by decapitation.  Ovariectomy was done in each rat, 
and the ovaries were frozen on dry ice and stored at -80 degree until processed for 
homogenization and Western Blotting. 
E-cadherin and β- catenin Identification and Quantification 
         E-cadherin and β-catenin protein expression was examined using Western Blots.  Each 
sample was homogenized using RIPA lysis buffer (Triton X-100 10%, Sodium Deoxycholate 
1%, SDS 0.10%, NaCl 0.15M, NaH2P04 0.01M, NaF 50mM,EDTA 2mM) containing Protease 
Inhibitor Cocktail (Thermo scientific, #78442) and the cell lysates extracted upon refrigerator 
centrifugation.  The protein concentration of the cell lysates were determined by Bicinchoninic 
acid Assay (BCA) protein (Pierce Biotechnology, Rockford, IL, USA).  Proteins were separated 
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by electrophoresis on 10% SDS-polyacrylamide gel and electro-transferred onto Hybond-ECL 
nitrocellulose membranes. Blotted membranes were blocked overnight with 5% skimmed milk 
and incubated with primary antibodies diluted 1 to 200 in 5% BSA.  Antibodies from Santa Cruz 
Biotechnology (Santa Cruz,CA,USA ) included E-cadherin (sc #3195) Beta-catenin (sc #2698). 
Beta actin was obtained from sigma (F3022).  After primary antibody incubation the blots were 
probed with appropriate secondary antibody conjugated with horseradish peroxidase.  The 
signal was visualized using Super Signal West Dura chemiluminescence substrate (Pierce 
Biotechnology).  Blot images were obtained using the G-box i-chemi XR CCD (Syngene 
Corporation). 
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CHAPTER 3 
RESULTS 
Leptin Effect on Body Weight  
     The body weight of RCD+ Saline (S), control, and HFD+ Saline (S) were monitored daily 
throughout the study with a use of digital scale (Mettler Toledo,OH).  The average data (table 1) 
and figure (figure 7) are showed below.  This parameter was measured in order to see the 
difference in body weight change as a result of the type of diet. There was a significant 
difference between the weight gain of RCD+S and HFD+S. The HFD+S had more weight gain 
than RCD+S. 
Table 1: This data shows the difference in the total weight gain at the end of the study between 
RCD+S (n=6) vs HFD+S (n=9) rats. 
Average Weight Gain of RCD+S and HFD+S At The End Of the Study(g) 
RCD+S HFD+S 
24.5 43.1 
28.8 35.5 
18.6 42.1 
8.3 25.1 
17 33.1 
30 33.4 
 44.6 
 28.5 
 30.3 
Mean Mean 
21.2 35.08 
SEM SEM 
3.35 2.29 
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Average Weight Gain of RCD+S and HFD+S at the End of the Study (g) 
 
Figure 7: Comparison of average body weight gain of RCD+S and HFD+S at the end of the 
study. The body weight gain of HFD+S was significantly (p<0.05) higher than RCD+S using a 
Two-sample t-test analysis. (* significant difference) 
 
 
Leptin Induces Weight Loss 
       By the 7th day, the oestrus cycle of those treated with leptin (n=5) started showing signs of 
regularity.  By the 13th day, the oestrus cycle of the 5 female rats (HFD+Leptin) became regular, 
and that of the remaining 9 HFD fed female rats were fully irregular.  A significant weight loss 
occurred in the HFD+Leptin (n=5) rats. The table (table 2) and figure (figure 8) below represent 
these changes. 
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Table 2:  Data representing the total body weight gain pre-leptin and total body weight loss post 
leptin treatment (n=5). 
    Average Weight Gain Pre-leptin And Total weight loss Post Leptin Treatment (g)    
Pre leptin (Weight gain) Post Leptin (Weight loss) 
32 15.3 
27.7 7.9 
7.4 6.4 
28.5 8 
24.3 13.9 
Mean Mean 
24 13.7 
SEM SEM 
4.33 3.64 
 
 
 
Figure 8: Average weight gain of pre- and post-leptin treatment. There was a significant 
(p<0.05) weight loss post-leptin treatment (n=5) using a Paired t-test analysis. (* significant 
difference) 
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Leptin Effect on Body Weight 
       Leptin treatment of rats with irregular oestrus cycle resulted in lower weight gain compared 
to RCD+S and HFD+S as shown in the table (table 3) and figure (figure 9) below. 
 
Table 3: This data represents the differences in the total weight gained of the RCD+S (n=6), 
HFD+Leptin (n=5), and HFD+S (n=9) at the end of 15 weeks 
 
   Average Weight Gain Of RCD+S, HFD+Leptin, and HFD+S At The End Of 15 Weeks (g) 
RCD+S HFD+Leptin HFD+S 
24.5 16.8 43.1 
28.8 19.8 35.5 
18.6 1.0 42.1 
8.3 20.5 25.1 
17 10.4 33.1 
30  33.4 
  44.6 
  28.5 
  30.3 
Mean Mean Mean 
21.2 13.7 35.08 
SEM SEM SEM 
3.35 3.64 2.29 
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              Average Weight Gain of RCD+S, HFD+Leptin, and HFD+S at the End of 15 Weeks 
 
Figure 9: Average weight gain Of RCD+S, HFD+leptin, and HFD+S at the end of 15 weeks.  
Using a One-way ANOVA analysis test, HFD+S (n=9) was significantly (p<0.05) higher than 
RCD+S (n=6) and HFD+Leptin (n=5) rats. (* significant difference)  
 
 
 
Leptin Reduces Amount of Food Intake 
         During this study, the amount of food intake by each rat was monitored everyday 
throughout the study with the use of a digital scale (Mettler Toledo,OH). This parameter was 
measured to determine if leptin reduces appetite.  Leptin caused reduction of the amount of 
food intake by these rats, which directly had an effect on their body weight change.  The 
HFD+leptin group of rats resulted in a significant reduction in food intake measured in kcal/day 
when compared to RCD+S and HFD+S as shown in the table (table 4) and figure (figure 10) 
below.  A gram of RCD diet correlates to 3.4 kcal, while a gram of HFD correlates to 4.73 kcal. 
After the treatment with leptin, there was reduction of food intake of HFD+leptin due to loss of 
appetite induced by effect of leptin. 
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Table 4:  Average food Intake (kcal/day) of RCD+S, HFD+S, and HFD+Leptin. 
 
Average Food Intake (kcal/day) 
RCD+S HFD+S HFD+Leptin 
45.76 52.79 43.04 
SEM SEM SEM 
0.02 0.05 0.03 
 
 
Figure 10: This figure shows the average food intake (kcal/day) of RCD+S, HFD+S, and 
HFD+Leptin.  The calorie intake of the HFD+S was significantly (p<0.05) higher than the 
RCD+S and HFD+leptin, using a One-way ANOVA analysis test. (* significant difference) 
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Leptin Modulates E-Cadherin and β-Catenin 
     Ovary cell lysate were analyzed for the expression of β-catenin and E-cadherin by Western 
Blot.  It was found that both of these proteins had higher expression levels in rats given RCD+S 
when compared to HFD+S and HFD+L.  There was a significant reduction of β-catenin and E-
cadherin in the HFD+S when compared to RCD+S as shown in the figure (figure 11) below.  
However, the rats fed HFD followed by leptin injection resulted in an increased expression of β-
catenin and E-cadherin compared to HFD+S, suggesting leptin induced a recovery from the 
almost total loss of expression of both β-catenin and E-cadherin due to the effect of obesity on 
infertility. 
 
 
 
 
 
 
Figure 11: Effects of leptin on expression of (a) β-catenin and (b) E-cadherin in obese 
infertile ovary cells.  Reversal of expression of both proteins in HFD+leptin towards the 
amount expressed in RCD+S, after almost total loss in HFD+S. (c) Expression of β-actin 
in the cells, serving as a form of loading control.  β-actin, a 44kDa primary antibody, is a 
house keeping gene that is always in the cell and serves as a form of loading control. This 
shows that the same amount and concentration of protein was loaded in each well. 
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CHAPTER 4 
DISCUSSION 
     Leptin is a pleiotropic hormone that has been found to be involved in many physiological 
functions in the body (9-11).  Although leptin has been found to reverse infertility (14), its role in 
infertility reversal in obese individuals has not yet been examined. The focus of this study is to 
propose the probable mechanism  of leptin in the reversal of infertility in dietary-induced obese 
infertile rats.   
     Our first observation was the role of leptin in energy intake and expenditure, which supports 
previous studies that show leptin regulates appetite, weight gain, and fat deposition via a 
negative feedback loop involving the hypothalamus (1-4).  It was observed that the rats given 
HFD+leptin had a reduction in their food intake that led to a significant weight loss when 
compared to rats given HFD+S. 
     Also, the role of leptin in fertility was observed.  HFD feeding for 15 weeks induced irregular 
oestrus cycle an indicator of infertility in all the rats. The regularity of oestrus cycle was 
determined by a 4-day cycle that consists of: proestrus, estrus, metestrus, and diestrus.  The 
ability of each rat to go through this cycle day by day without skipping any stage signified a 
regular oestrus cycle.  Two weeks post-leptin injection in the treated group, the irregular oestrus 
cycle became regular.  Leptin is known to reverse infertility in ob/ob infertile rats (14). 
Exogenous leptin replacement has been found to rescue the infertility of ob/ob females (20).  
Elevated serum luteinizing hormone, increase in ovarian and uterine weights, and stimulation of 
ovarian and uterine histology has been documented with exogenous leptin replacement (20). 
Some studies have supported the concept of leptin coordinating the behavioral and endocrine 
components of reproductive functions (44-45). 
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      Although recent studies have shown that leptin reverses infertility in ob/ob infertile rats (20), 
the pathway of reversal is poorly understood.  This study will be the first to show the correlation 
between leptin and a potential pathway in the reversal of fertility in dietaryly induced obese 
infertile rats. The possibility of calorie restriction/and or weight loss pathway has been excluded 
(14, 16).  
     Most importantly, studies have shown that E-cadherin/β-catenin complex is among the 
structural molecular constituents that assemble to form the adherens-junctions (53).  These 
adherens junction are needed for the creation and maintenance of epithelial cell layers, which is 
achieved by regulating cell growth and adhesion between cells (53).  This complex has also 
been found to play a crucial role in maintaining epithelial integrity and cell proliferation (35).  
Expressions of E-cadherin and β-catenin were found to be increased in the theca and interstitial 
cells of the rat ovaries during follicular development (58, 64, 65).  However, granulosa cells had 
more expression of β-catenin (58, 64, 65).  The concentration of E-cadherin and β-catenin were 
found to be constant during the follicular phase and present in most ovarian cells at all stages of 
folliculogenesis (58, 64, 65).  Folliculogenesis is the process of attaining successively higher 
levels of cell organization by means of cytodifferentiation and cell proliferation of the ovarian 
follicle (60).  The conversion of primordial follicles to primary follicles involves the development 
of intimate intercellular connections between the oocyte and granulosa cells (63, 29). The 
effectiveness of this cell-cell contact is determined by the competency of adherens junction and 
gap junction at this region (59).  The intimate intercellular connections between the oocyte and 
granulose cells are important in primary follicle development (59).  Also, primary-to-secondary 
transition involves the ability to stimulate granulosa cell proliferation and continual development 
of inter-cellular junction system between the granulosa cells and oocyte-granulosa intercellular 
connections (59).  The importance of oocyte-granulosa intercellular connections in primordial 
follicles-primary follicles transition and the stimulation of granulosa cell proliferation and 
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continual development of intercelluar junctional system between the granulose cell and oocyte-
granulosa connections (59), make the E-cadherin/β-catenin complex a potential candidate for a 
crucial role in folliculogenesis.  
      In our studies, not did we only demonstrate that E-cadherin and β-catenin are expressed in 
the rat ovary and that HFD reduced their expression, but surprisingly we also showed that leptin 
treatment modulates the expression of these proteins in these dietary-induced obese infertile 
rats. The expression of E-cadherin and β-catenin was markedly reduced in ovaries of rats that 
were fed with high fat diet (HFD) and reversed expression of these proteins when they were 
treated with leptin intra-peritoneally.  Because E-cadherin/β-catenin complex has been found to 
be involved in all stages of folliculogenesis (38,41), observations made in this study suggest that 
leptin has a functional role in the expression of E-cadherin and β-catenin complex in improving 
fertility in obese infertile rats and could therefore be important in folliculogenesis and ovulation. 
This could be a novel finding of the potential pathway by which leptin acts in reversing infertility 
in these rats. 
Future Directions  
      A long-term study including measurement of all the hormones involved in reproduction is 
needed.  The ovarian and uterine weights should also be measured.  In respect to the counter 
effects of E-cadherin and β-catenin that have been recently found to be involved in development 
of cancer and its metastasis (25,34), it will be of interest to know if these leptin treated rats will 
develop ovarian cancer or polycystic ovarian disease when they are left for a longer period of 
time. 
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